While US companies struggle with the impact of the strong dollar on their international revenues, FTSE 100 companies which have costs in sterling but record their sales in dollars should be quids in.

The dollar may have come back a bit recently but taken on a medium-term view its performance against other currencies has been remarkable.

And although most companies hedge their currency exposure each year in order to limit the impact of negative movements, a lot of finance directors will have looked at the outlook for this year and concluded that by not hedging their dollar exposure as much they could see a positive impact on profit.

As long as the Federal Reserve sticks to its gameplan of keeping interest rates higher for longer to try and stamp out inflation, there is little to stop the appreciation of the dollar against other world currencies.

So far the beneficiaries include food and household goods giant Unilever (ULVR), the third-largest stock in the FTSE 100 index, which posted third quarter results last week showing turnover grew by 17.8%, of which almost half (8.8%) came from favourable currency moves.

Chief executive Alain Jope raised the firm’s full year guidance for a second time, predicting underlying sales growth of 8% compared with ‘over 6.5%’ previously thanks to price rises and currencies.

Personal care group Reckitt (RKT), which also reported earnings last week, revealed that over half of its reported 14% sales growth for the third quarter was thanks to a tailwind from the strong dollar.

The firm said that if exchange rates stayed where they were at the end of September there would be a positive effect on sterling sales for the year of around 6% while earnings per share would get a 9% to 10% lift.

Surprisingly, Barclays (BARC) is also on the list of winners as it books between 40% and 45% of its income in dollars but only 30% of its costs, so its profit margin has been helped by the recent surge in the US currency.

Looking ahead, drinks group Diageo (DGE), which like Unilever and Reckitt counts the US and emerging markets – where sales are also typically accounted for in dollars – as its biggest regions, suffered a currency headwind in the year to June but will likely enjoy a boost to revenues and earnings after the rapid climb of the dollar since the summer.

Similarly, drugs group AstraZeneca (AZN), the second-biggest stock in the FTSE 100, is likely to have enjoyed a significant currency tailwind in the third quarter when it reports its latest earnings on 10 November. 

‹ Previous2022-11-03Next ›